LTRN Stock Analysis: Buy, Sell, or Hold?
LTRN - Lantern Pharma Inc. Common Stock
$3.15
0.04 (1.29%)
▲
HOLD
LOW Confidence
Last Updated: January 30, 2026
Get Alerted When LTRN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LTRN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: LTRN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: LTRN is currently trading at $3.15, which is considered oversold relative to its 30-day fair value range of $3.20 to $3.51.
Technical Outlook: Technically, LTRN is in a strong downtrend. Immediate support is located at $2.96, while resistance sits at $3.59.
Market Sentiment: LTRN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (20th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $22.00 (+607.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LTRN is in a strong downtrend. Immediate support is located at $2.96, while resistance sits at $3.59.
Market Sentiment: LTRN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (20th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $22.00 (+607.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$3.20 -
$3.51
Company Quality Score
48/100
(HOLD)
Options IV Signal
20th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
66.7%
Protect Your Profits
Holding LTRN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 20th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 607.4% below Wall St target ($22.00)
- CAUTION: Recommendation downgraded due to -9.0% 5-day decline
Fair Price Analysis
30-Day Fair Range
$3.20 -
$3.51
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.91
(28.8%)
Support & Resistance Levels
Support Level
$2.96
Resistance Level
$3.59
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.04
Wall Street Target
$22.00
(+607.4%)
Last updated: January 31, 2026 2:11 AM ET
Data refreshes hourly during market hours. Next update: 3:11 AM
Data refreshes hourly during market hours. Next update: 3:11 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LTRN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$214 | 60 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 56 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$273 | 59 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$19 | 55 HOLD |
Advanced LTRN Option Strategies
Professional options setups generated by AI based on today's LTRN price and gamma walls.
